AMPK is a serine/threonine protein kinase family and we recently identified a novel member, ARK5. The activation of ARK5 is triggered by Akt, and ARK5 induces tumor cell survival during nutrient starvation. In the current study, we investigated the mechanisms of induction of cell survival by ARK5. Human hepatoma HepG2 cells undergo necrotic cell death within 24 h after the start of glucose starvation, and the cell death signaling has been found to be mediated by death-receptor-independent activation of caspase 8. When HepG2 cells were transfected with ARK5 expression vector and subjected to several cell death stimuli, ARK5 was found to suppress cell death by glucose starvation, TRAIL, and TNF-a, but not by ultraviolet irradiation, camptothecin, or doxorubicin. Western blotting analysis revealed that both TRAIL and glucose starvation induced Bid cleavage and FLIP degradation following caspase 8 activation in a timedependent manner, and ARK5 overexpression clearly delayed Bid cleavage, FLIP degradation, and caspase 8 activation. On the basis of the results of this study, we report that cell survival induced by ARK5 is, at least in part, due to inhibition of caspase 8 activation.
Introduction
Since tumor cell proliferation and survival are basically maintained by oxygen and nutrients, especially glucose, supplied by the blood, it has been widely accepted that angiogenesis is closely involved in tumorigenesis, and its involvement has been confirmed in various clinical cancers (Folkman, 1974; . Recently, however, we demonstrated that some tumor cells, such as pancreatic cancer cells, exhibit tolerance to nutrient starvation (Izuishi et al., 2000; Kato et al., 2002) , and that hypoxia induces tolerance to nutrient starvation even in angiogenesis-dependent tumor cells Hashimoto et al., 2002) . Based on these observations, we proposed that tolerance to nutrient starvation might be another determinant of cancer cells that allows them to overcome hypoxic conditions, and previously we demonstrated that two serine/threonine protein kinases, Akt and AMP-activated protein kinase (AMPK), are closely involved in the tolerance (Izuishi et al., 2000; Esumi et al., 2002; Hashimoto et al., 2002; Kato et al., 2002) .
Akt, which is well known as a cell survival factor, is activated by stimulation with several growth factors via phosphatidylinositol-3 kinase, PDK1, or Rac/Cdc42 (Kennedy et al., 1997; Delcommenne et al., 1998; Datta et al., 1999; Higuchi et al., 2001; Brazil et al., 2002) , and the activated Akt phosphorylates several factors, including Bad, Forkhead, caspase 9, and Mdm2 (Brazil et al., 2002) . Recently, we demonstrated that AMPK also acts as a cell survival factor (Izuishi et al., 2000; Esumi et al., 2002; Hashimoto et al., 2002; Kato et al., 2002) . Four genes, AMPK-a1, AMPK-a2 (Mitchelhill et al., 1994; Stapleton et al., 1996) , MELK (Heyer et al., 1997) , and SNARK (Lefebvre et al., 2001) , have been identified in the AMPK family, and we identified a fifth member and designated it as ARK5 (Suzuki et al., 2003) . ARK5 is also a cell survival factor, and its activation, which is regulated by Akt, induces tolerance to nutrient starvation (Suzuki et al., 2003) . Thus, the Akt/ARK5 pathway is a new signaling pathway for the induction of the cell survival that is closely involved in tumorigenesis.
Several cell-death-associated factors are activated during induction of cell death. Caspase is the cell death-associated cysteine protease (Alnemri et al., 1996) , and its activation is directly involved in several modes of cell death via cleavage of poly(ADP-ribose) polymerase, lamin, and DFF45/ICAD (Nagata, 1997). As described above, the cell survival factor Akt phosphorylates the cell death promoters Bad (Datta et al., 1997) and caspase 9 (Cardone et al., 1998) , thereby suppressing their biological functions. While Akt alone induces cell survival via inhibition of cell-death-promoting factors, we also demonstrated an important role of the Akt/ ARK5 pathway during cell survival signaling. Since it remained unclear as to how ARK5 induces cell survival at the downstream of Akt, in the current study, we investigated whether ARK5 suppresses cell death signaling induced by death-receptor activation, chemotherapeutic agents, and DNA double-strand breaks, as an approach to determining the molecular mechanism of ARK5-induced cell survival.
Results and discussion
Necrotic cell death in HepG2 cells induced by glucose starvation is mediated by death-receptor-independent caspase 8 activation
We have reported that the human hepatoma cell line HepG2 readily undergoes cell death when the cells are subjected to glucose starvation (Izuishi et al., 2000; Esumi et al., 2002; Kato et al., 2002) ; however, since the precise mechanism of the cell death had never been determined, in the present study, we investigated the mechanism of glucose-starvation-induced cell death. After glucose starvation of HepG2 cells for 24 h, the nuclei were stained with PI, and no nuclear fragmentation or condensation were observed when stained with Hoechst 33342/PI (Figure 1a) . The phenotype of cell death induced by glucose starvation in HepG2 cells was also examined using PI/Annexin V staining. As shown in Figure 1a , cells subjected to glucose starvation showed the PI staining, but not Annexin V staining, similar to cells treated with DMSO. In contrast, prominent staining with Annexin V of cells was observed by TRAIL treatment (Figure 1a ). Moreover, a comet assay was performed to examine whether cell death induced by glucose starvation was due to DNA double-strand breaks. When HepG2 cells were irradiated by UV (60 mJ), DNA double-strand break, which was accompanied by the appearance of comet, was observed after 24 h (Figure 1b) . In contrast, 24 h glucose starvation did not induce DNA double-strand breaks (Figure 1b) . Since PI staining of nuclei without nuclear damage has been characterized as representing necrotic cell death , our results showed that glucose starvation induced necrotic cell death of HepG2 cells. A similar necrotic cell death during longer glucose starvation was observed in various cell lines: human pancreatic cancer cell line PANC-1, and human colorectal adenocarcinoma cell lines DLD-1 and SW480 (data not shown).
Caspase is the cell death-associated cysteine protease, and it mediates several cell-death signalings (Alnemri et al., 1996) . Since the necrotic cell death induced by chemical hypoxia has been reported to be suppressed by caspase inhibitors and antiapoptotic factor Bcl-2 (Tsujimoto et al., 1984; Vaux et al., 1988; Shimizu et al., 1996) , suggesting that some necrotic cell death is also mediated by caspase, in the present study therefore, we used a Western blotting procedure to investigate whether the necrotic cell-death signaling is mediated by caspase. Among the caspases tested, caspases 3, 6, 8, and 9, caspase 8 was found to undergo proteolytic activation during glucose starvation (Figure 1c ). The After 24 h, cells were cultured for 24 h in a medium containing glucose (Control) or not containing glucose (DS: upper), or containing 50 ng/ml TRAIL (DS: lower), and cell survival was measured. HepG2 cells treated with zVAD.fmk (zVAD) were also cultured for 24 h in a medium not containing glucose (upper) or containing TRAIL (lower). Cell viability is shown as the mean of three experiments, and the bars represent the s.e. values. (e) HepG2 cells not pretreated (none) and pretreated with monoclonal antibody against CD95 (1 mg/ml) and Fc-fusion protein of TNF-R1, TRAIL-R1, and TRAIL-R2 (500 ng/ml) for 24 h were subjected to glucose starvation for 24 h. After 24 h, the cells were subjected to glucose starvation, and cell survival was measured. Cell viability is shown as the mean of three experiments, and the bars represent the s.e. values
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A Suzuki et al Bcl-2 family protein Bid is well known as the caspase 8 substrate (Wang et al., 1996; Li et al., 1998; Luo et al., 1998) , and Bid cleavage has been found to correlate well with caspase 8 activation during glucose starvation ( Figure 1c ). Cleaved Bid is known to stimulate the mitochondrial death pathway (Li et al., 1998; Luo et al., 1998) , and thus, our results suggest that glucose starvation might induce the mitochondrial death pathway via Bid cleavage following caspase 8 activation. Caspase 8 contains two functional regions: one is a death effector domain needed for interaction with FADD and the other is the caspase domain (Boldin et al., 1996; Muzio et al., 1996) . Caspase 8 activation is generally initiated upon stimulation of death receptors, namely CD95, TNF-R1, and TRAIL-R1/2, through interaction with FADD, and the complex with FADD and caspase 8 is referred to as DISC (death-inducing signaling complex; Kischkel et al., 1995) . Since deathreceptor-independent caspase 8 activation has recently been reported during anchorage-independent cell death, anoikis (Stupack et al., 2001) , we investigated whether caspase 8 activation during glucose starvation is dependent or independent of death receptors. When cells were treated with a broad inhibitor of caspase, zVAD.fmk, or transiently expressed DN-FADD and FLIP, glucose starvation-induced cell death was clearly suppressed by zVAD.fmk and partially by FLIP, but not by DN-FADD (Figure 1d ). Since these three clearly suppressed cell death induced by TRAIL (Figure 1d) , the above results indicate that glucose starvationinduced cell death is a caspase-dependent and deathreceptor-independent one. In addition, the results also indicate that an interaction between FADD and caspase 8 might be also involved in glucose starvation-induced cell death, since FLIP is well known to inhibit the interaction (Irmler et al., 1997; Thome et al., 1997; Scaffidi et al., 1999) . The DN-FADD used in the current study contains only the death domain (Chinnaiyan et al., 1995) . It suppressed caspase 8 activation by TRAIL, but not by glucose starvation. In addition, glucose starvation-induced necrotic cell death was not suppressed by neutralization of death receptors (Figure 1e ). Taken together, these results indicate that caspase 8 activation by glucose starvation is independent of death-receptor activation, the same as anoikisinduced cell death.
ARK5 inhibits cell death signaling induced by glucose starvation and death ligand, but not by UV irradiation or chemotherapeutic agents
We have reported that tolerance to glucose-starvationinduced cell death is largely dependent on 5 0 -AMPactivated protein kinase Kato et al., 2002) , and we recently identified a novel AMPK family member ARK5 and found that it suppresses glucose starvation-induced cell death (Suzuki et al., 2003) . In the current study, therefore, we examined whether ARK5 overexpression can suppress cell death in HepG2 cells by other stimuli in order to clarify the mechanism of action of ARK5.
HepG2 and its ARK5-stably overexpressing line H/ ARK (Suzuki et al., 2003) cells were exposed to six cell death stimuli: glucose starvation, as a metabolic stress, ultraviolet (UV) irradiation, as thymidine dimer-induced DNA damage (Kulms and Schwarz, 2002) , death-receptor stimulation with TRAIL (Pan et al., 1997; Sheridan et al., 1997; Yamanaka et al., 2000) and TNF-a (Gupta, 2001) , and the DNA damage-inducing chemotherapeutic agents, camptothecin (CPT), which suppresses topoisomerase-I (Kaufmann, 1998) , and doxorubicin (Dox), which suppresses DNA replication (Lage and Dietel, 1999) . As shown in Figure 2a , within 24 h HepG2 cells showed a significant decrease in cell viability in response to all death stimuli and the H/ARK cells showed clear resistance to cell death by glucose starvation (HepG2: 16.4%; H/ARK: 57.4%), TRAIL (HepG2: 9.7%; H/ARK: 30.3%), and TNF-a (HepG2: 12.9%; H/ARK: 33.4%). However, ARK5 did not influence cell death caused by DNA damage, UV (HepG2: 57.2%; H/ARK: 49.5%), CPT (HepG2: Figure 2 Effect of ARK5 on response to cell death stimuli. (a) The HepG2 (open) or H/ARK (closed) cell line was exposed to or not exposed to several cell death stimuli for 24 h. After 24 h, cells were subjected to glucose starvation (Glc (À)) and cell survival was measured. Cell viability is shown as the mean of three experiments, and the bars represent the s.e. values. UV irradiation (UV): 60 mJ; TRAIL: 50 ng/ml; TNF-a (TNF): 20 ng/ml; CPT: 100 ng/ml; Dox: 100 ng/ml. (b) The HepG2 (open) or H/ARK (closed) cell line was subjected to glucose starvation, TRAIL (50 ng/ml), or TNF-a (20 ng/ml) for each period. After treatment, cells were subjected to glucose starvation, and cell survival was measured. Cell viability is shown as the mean of three experiments, and the bars represent the s.e. values Tumor cell survival by ARK5 A Suzuki et al 42.5%; H/ARK: 32.5%), and Dox (HepG2: 43.4%; H/ARK: 49.9%). ARK5 delayed the cell death by glucose starvation, TRAIL, and TNF-a ( Figure 2b ). As shown in Figure 3 , all death stimuli used in the current study are known to be mediated by the mitochondrial death pathway (Nagata, 1997; Green and Reed, 1998) . Death-receptor stimulations and glucose starvation induce caspase 8 activation as a result of DISC recruitment, and active caspase 8 induces the release of cytochrome c, a component of apoptosomes, from mitochondria through Bid cleavage. By contrast, cytochrome c release from mitochondria during cellular response to DNA breakage is mediated by c-Myc, Bad, and p53, but not by caspase (Green and Reed, 1998) . Therefore, we speculated that caspase 8 and/or its related factor(s) must be the target for ARK5.
Effect of ARK5 on caspase 8 activation, Bid cleavage, and FLIP degradation
We hypothesized that ARK5 suppresses cell death signaling through an inhibition of caspase 8 activation.
To test this hypothesis, therefore, proteolytic activity of caspase 8 was measured in HepG2 or H/ARK cells exposed to glucose starvation or TRAIL using the specific substrate, IETD-p-nitroanilide (p-NA). As shown in Figure 4a , both glucose starvation and TRAIL treatment dramatically activated caspase 8 even at 6 h after treatment, and the time-dependent activation was observed. However, caspase 8 activation in H/ARK cells treated with glucose starvation or TRAIL showed little increase at 6 h after treatment, followed by a moderate increase at 12-24 h after treatment, indicating that ARK5 delayed caspase 8 activation (Figure 4a ). In addition, expressions of Bid (caspase 8 substrate) and FLIP (caspase 8 inhibitor) were examined with Western blotting. As shown in Figure 4b , ARK5 did not influence Bid and FLIP expressions in cells exposed to 24 h cell death stimulation (glucose starvation and TRAIL treatment). Both Bid and FLIP showed a (open) or H/ARK (closed) cell lines subjected to glucose starvation (Glc (À)) or combined exposure to TRAIL (50 ng/ml) and actinomycin D (0.3 mg/ml) (TRAIL) for each period, and then protease activity of caspase 8 was measured. Protease activity is shown as the mean of three experiments, and the bars represent the s.e. values. (b) HepG2 (HG) or H/ARK (HA) cell line was subjected to glucose starvation (Glc (À)) or combined exposure to TRAIL (50 ng/ml) and actinomycin D (0.3 mg/ml) (TRAIL) for 0-24 h. Cell extracts were then collected, and Western blotting with polyclonal antibody against human Bid or FLIP was performed. (c) FLIP mRNA expression was observed in total RNAs extracted from HepG2 or H/ARK cell lines subjected to glucose starvation (Glc (À)) or combined exposure to TRAIL (50 ng/ml) and actinomycin D (0.3 mg/ml) (TRAIL) for 0-24 h. PCR was performed at 30 cycles (Irmler et al., 1997; Thome et al., 1997) , and it has been reported that degradation of FLIP sensitizes cells to TRAIL-induced cell death (Kim et al., 2002) . In the current study, FLIP overexpression suppressed cell death in HepG2 cells exposed to a glucose-free medium (Figure 1d) , and Western blotting analysis in HepG2 and H/ARK cells revealed that ARK5 delayed FLIP degradation during cell death signaling. RT-PCR revealed that both glucose starvation and TRAIL treatments significantly decreased FLIP mRNA even at 6 h after treatment, and down to complete disappearance at 12-24 h after treatment (Figure 4c ). In contrast, FLIP mRNA in H/ARK cells did not change at 6 h after treatment, and its decrease was observed at 12 h after treatment (Figure 4c ), indicating that ARK5 clearly delayed a decrease in FLIP mRNA expression during cell death signaling. In addition, decreased expression of FLIP mRNA correlated well with an increase of caspase 8 activity, suggesting that the delay of caspase 8 activation by ARK5 might be due to the retention of FLIP mRNA. Recently, the possible involvement of both the Akt and AMPK family members in FLIP mRNA transcription has been reported (Nam et al., 2002) . Since the fifth member of the AMPK family, ARK5, is directly activated by Akt, the Akt-induced FLIP mRNA transcription might be mediated by ARK5. On the basis of our current results, we suggest that the molecular mechanism of cell survival induced by ARK5 is due to an inhibition of caspase 8 activation and that the inhibition is caused by delayed degradation of FLIP.
Cells and procedures

Cell line and transfection
Human hepatoma cell line HepG2 was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS; Sigma Chemical Co., Ltd., St Louis, MO, USA). For transfection, cells were seeded into a six-well plate at 2.5 Â 10 5 /well, and transfection was performed using TransFast Transfection Reagent (5 mg DNA/well: Promega Corporation). The exposure time of the transfection reagent to cells was 4 h. The transfection yield was measured with a GFP-inserted expression plasmid, and it was 70-80%.
Chemicals, recombinant proteins, and antibodies
CPT, Dox, TNF-R1:Fc, and TRAIL-R2:Fc were purchased from Alexis Corp. (San Diego, CA, USA). TRAIL-R1:Fc was purchased from Dako Japan (Kyoto, Japan). Anti-human CD95 monoclonal antibody (ZB4 clone) and anti-human FADD antibody were purchased from the Medical and Biological Laboratory (MBL, Nagoya, Japan). Polyclonal antibodies against human caspase 8 and human Bid were purchased from Upstate Biotechnology Inc. (Lake Placid, NY, USA) and Trevigen Inc. (Gaithersburg, MD, USA). Caspase 8 protease activity was measured with Caspase 8 Activity Colorimetric Assay Kit purchased from MBL.
Western blotting procedure
Proteins were prepared for Western blotting analysis by lysing of cells for 30 min with a buffer containing 1% NP-40. All procedures were carried out at 41C. Proteins were collected by centrifugation at 15 000 r.p.m. for 15 min, and their concentrations were determined with a BCA protein assay kit (Pierce) using bovine serum albumin as the standard.
Sample proteins separated by SDS-PAGE were transferred onto nitrocellulose membranes by a semidry blotting system. The membranes were blocked at room temperature for 1 h with PBS containing 5% (w/v) skim milk (Becton Dickinson Co.), washed with a mixture of PBS and 0.05% Tween 20 (Sigma, Tween-PBS), and then incubated overnight at room temperature with an antibody diluted with PBS. After washing with Tween-PBS, the membranes were incubated with a 2000-fold HRP-conjugated anti-rabbit/mouse IgG antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at room temperature for 60 min. The membranes were then washed with Tween-PBS and then developed with the ECL system (Amersham Pharmacia Biotech K.K., UK).
Cell survival assay
Cell viability was assessed by the Hoechst 33342/PI staining procedure, as previously described (Hasegawa et al., 1996) . Hoechst 33342 and PI were purchased from Molecular Probes, Inc. After incubation, the cells were collected and stained with Hoechst 33342 and PI, and then examined by fluorescence microscopy. The cell death induction ratio was calculated as the ratio of cells carrying PI-stained nuclei to total cells (approximately 500 cells).
Comet assay
Comet assay was performed with a Comet Assay Kit (Trevigen). After treatment, cells were embedded in lowmelting agarose on a comet slide chamber. The slides were then electrophoresed at 100 V for 5 min and stained with SYBR Green. After staining, cells were examined under a fluorescent microscope.
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